Clinical Trial

Study on Acupuncture Treatment of Chronic Airway Diseases(Asthma and Chronic Obstructive Pulmonary Disease)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
For patients in the acute phase of chronic airway diseases, on the basis of guideline-directed treatment, the experimental group was given acupuncture treatment, while the control group was given sham acupuncture treatment. The treatment lasted for one week, followed by a 13-week follow-up. For asthma and COPD, PEF and CAT were respectively used as the primary outcome measures to evaluate the clinical efficacy and safety of acupuncture. Based on the improvement of the primary outcome measures, the advantageous population was identified. The mechanism by which acupuncture reduces airway mucus hypersecretion was preliminarily explained.
Trial Details
NCT Number NCT06869525
Lead Sponsor Henan University of Traditional Chinese Medicine
Collaborators: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Hebei Provincial Hospital of Traditional Chinese Medicine
Conditions COPD Exacerbation Acute, Asthma Acute
Enrollment 576 participants
Start Date 2025-03
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-11